Beth Fehrle
Director, Operations at MMS
- Role
- Director, Operations at MMS
- Location
- Ann Arbor, MI, US
- LinkedIn followers
- 500 followers
About Beth Fehrle
With more than 20 years of experience in the pharmaceutical industry, I am Director, Operations at MMS – a global, leading clinical research organization. On a daily basis, I work with the global team members to ensure outstanding services that meet regulatory requirements and high-quality standards.Prior to my tenure at MMS, I spent over 15 years at Pfizer where I led the regulatory operations team supporting global regulatory submissions across many therapeutic areas and indications as Associate Director.As a leader, I am a focused on encouraging the skills and strength of each individual that contribute to our exceptional high-quality services.
Experience
Director, Operations
Jan 2022 — Present
Provides oversight and coordination of operational projects and activities with a focus to improve efficiency, increase communication and streamline processes. Appointed to the Company’s Innovation Leadership Team in the January 2022.
Education
Baker College
MBA, Business Administration and Management
2001 — 2005
Eastern Michigan University
Bachelor's of Science
1984 — 1988
Skills
- Biotechnology
- Oncology
- Protocol
- Medical Devices
- Clinical Trials
- Clinical Development
- U.s. Title 21 Cfr Part 11 Regulation
- Regulatory Requirements
- Electronic Data Capture (Edc)
- Pharmaceutical Industry
- Communication
- CRO
- Regulatory Affairs
- Medical Writing
- Edc
- Ctms
- Pharmaceutics
- Drug Discovery
- Clinical Trial Management System (Ctms)
- Regulatory Submissions
- 21 Cfr Part 11
- Drug Development
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.